ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines

Zinc Finger and BTB Domain-containing7A (ZBTB7A) is a member of the transcription factor family that regulates the expression of numerous genes involved in cell proliferation and differentiation. Ubiquitously expressed in colon, stomach, and other tissues, ZBTB7A performs diverse functions including hematopoiesis, metabolism, and oncogenesis. Here we showed that ZBTB7A knockout inhibited the growth of colon cancer cells and reduced CD95 protein expression by decreasing CD95 mRNA transcription. Overexpression of ZBTB7A could partially restore both CD95 expression and CD95-mediated downstream Caspase2 and JNK2 expression. Furthermore, treatment with ZBTB7A specific inhibitor Curcumin effectively induced colorectal cancer cell death while reducing CD95 expression. These data indicate that ZBTB7A promotes colon cancer cell growth and survival, suggesting its potential as a therapeutic target for colorectal cancer.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-09-15
DOI
https://doi.org/10.1371/journal.pone.0329958
Citations
1
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines

Shufang Tao, Yanhong Bie, Linlin Kuang, Maaike de Bie et al.
1 citations
PLoS ONE
Drug Transport and Resistance Mechanisms
1.05
article

ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines

Shufang Tao, Yanhong Bie, Linlin Kuang, Maaike de Bie, Yi Song, Wenyu Liu, Hongyu Xing
article en
1 citations

Abstract

Zinc Finger and BTB Domain-containing7A (ZBTB7A) is a member of the transcription factor family that regulates the expression of numerous genes involved in cell proliferation and differentiation. Ubiquitously expressed in colon, stomach, and other tissues, ZBTB7A performs diverse functions including hematopoiesis, metabolism, and oncogenesis. Here we showed that ZBTB7A knockout inhibited the growth of colon cancer cells and reduced CD95 protein expression by decreasing CD95 mRNA transcription. Overexpression of ZBTB7A could partially restore both CD95 expression and CD95-mediated downstream Caspase2 and JNK2 expression. Furthermore, treatment with ZBTB7A specific inhibitor Curcumin effectively induced colorectal cancer cell death while reducing CD95 expression. These data indicate that ZBTB7A promotes colon cancer cell growth and survival, suggesting its potential as a therapeutic target for colorectal cancer.

PLoS ONEVol. 20(9)
Chinese Academy of Sciences (CN), Jiading District Central Hospital (CN), Pudong Maternal and Child Health Hospital (CN), Shanghai Traditional Chinese Medicine Hospital (CN), Shanghai Sunshine Rehabilitation Center (CN)
Openalex Percentile: Top 18%
Drug Transport and Resistance Mechanisms
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ZBTB7A regulates CD95-mediated cell growth in colorectal cancer cell lines — Shufang Tao, Yanhong Bie, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS